DC4U is a life science company developing technologies that enable steering the human immune response. Our GlycoDCTM technology can either potentiate or suppress the immune system via specific targeting of dendritic cells by glycan modified antigen conjugates.More info >
DC4U’s GlycoDCTM dendritic cell targeting technology can be applied to significantly enhance anti-tumor immunity…More info >
DC4U’s GlycoDCTM targeting technology can be applied to achieve restoring tolerance in allergic patients….More info >
DC4U’s GlycoDCTM targeting technology can be applied to restore tolerance in allergic patients. This…More info >
DC4U’s GlycoDCTM dendritic cell targeting technology could be applied to enhance traditional prophylactic vaccine…More info >
DC4U’s GlycoDCTM targeting technology can be applied to achieve suppression of autoimmune responses. This…More info >
DC4U’s GlycoDCTM Targeting Technology can be applied in the treatment of inflammatory diseases. This…More info >
